(Q51762779)

11 April 2018

title

Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. (English)

1 reference

11 April 2018

0 references

1 reference

Yingyos Avihingsanon

1

1 reference

11 April 2018

Thitima Benjachat

2

1 reference

11 April 2018

Adis Tassanarong

3

1 reference

11 April 2018

Pimpayao Sodsai

4

1 reference

11 April 2018

Vipawee Kittikovit

5

1 reference

11 April 2018

Nattiya Hirankarn

6

1 reference

11 April 2018

language of work or name

English

0 references

publication date

18 March 2009

1 reference

11 April 2018

published in

Kidney International

1 reference

11 April 2018

volume

75

1 reference

11 April 2018

issue

12

1 reference

11 April 2018

page(s)

1340-1348

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1038/ki.2009.75

exact match

0 references

cites work

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Systemic lupus erythematosus and the type I interferon system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Pathogenesis of lupus nephritis: an update

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Renal mRNA levels as prognostic tools in kidney diseases.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Cytokine expression in lupus kidneys

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

The pathology of lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

VEGF(165) mediates glomerular endothelial repair

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Cellular responses to hypoxia after renal segmental infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Hypokalemic nephropathy is associated with impaired angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Urinary podocytes for the assessment of disease activity in lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

The classification of glomerulonephritis in systemic lupus erythematosus revisited

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.75

7 January 2021

Identifiers

DOI

10.1038/KI.2009.75

1 reference

11 April 2018

release_zal7qhx6tnbjjiuz6iplm3hr3q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zal7qhx6tnbjjiuz6iplm3hr3q

24 November 2022

mapped directly with Wikidata item

1 reference

11 April 2018